Pancreatic Ductal Adenocarcinoma — Trials

Pancreatic Ductal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

415 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 209
Recruiting: 129
Ph III recruiting: 13
Growth YoY: +47.9%
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–25 of 25 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06147037	A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours	active not recruiting	Phase 1	13	AstraZenecaINDUSTRY	2	Sep 30, 2026	clinicaltrials
NCT06305247	A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours	active not recruiting	Phase 1 / Phase 2	36	IpsenINDUSTRY	3	Sep 30, 2026	clinicaltrials